• 1
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716721.
  • 2
    Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. HEPATOLOGY 1998; 28: 4549.
  • 3
    Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 27182723.
  • 4
    Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. HEPATOLOGY 2004; 39: 739745.
  • 5
    Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 19031909.
    Direct Link:
  • 6
    Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004; 291: 12381245.
  • 7
    Evans L. The dominant role of driver behavior in traffic safety. Am J Public Health 1996; 86: 784786.
  • 8
    Talwalkar JA, Kamath PS. Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc 2005; 80: 15011508.
  • 9
    Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umilta C. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 2005; 20: 115127.
  • 10
    Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768773.
  • 11
    Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42(Suppl): S45S53.
  • 12
    Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005; 20: 359367.
  • 13
    Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umilta C, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 2005; 20: 381392.
  • 14
    Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J. Knowing where and getting there: a human navigation network. Science 1998; 280: 921924.
  • 15
    Kolb B, Whishaw IQ. Spatial behavior. In: KolbB, WhishawIQ, eds. Fundamentals of Human Neuropsychology. 5th ed. New York: Worth Publishers; 2003: 643676.
  • 16
    Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, et al. A multimodal assessment of driving performance in HIV infection. Neurology 2004; 63: 14171422.
  • 17
    Cherrier MM, Mendez M, Perryman K. Route learning performance in Alzheimer disease patients. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 159168.
  • 18
    Tetewsky SJ, Duffy CJ. Visual loss and getting lost in Alzheimer's disease. Neurology 1999; 52: 958965.
  • 19
    Wechsler D. Wechsler Adult Intelligence Scale III. San Antonio, TX: Psychological Corp; 1999.
  • 20
    Bajaj JS, Saeian K, Verber MD, Mischke D, Hoffman RG, Franco J, et al. Inhibitory control test is a simple method to diagnose minimal encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007; 102: 754760.
    Direct Link:
  • 21
    Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A 1999; 96: 83018306.
  • 22
    Pliszka SR, Liotti M, Woldorff MG. Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000; 48: 238246.
  • 23
    Ford JM, Gray M, Whitfield SL, Turken AU, Glover G, Faustman WO, et al. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 2004; 61: 119129.
  • 24
    Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002; 8: 655672.
  • 25
    Lenne MG, Triggs TJ, Redman JR. Interactive effects of sleep deprivation, time of day, and driving experience on a driving task. Sleep 1998; 21: 3844.
  • 26
    Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, et al. The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc 1999; 5: 579592.
  • 27
    Ware JC, Risser MR, Manser T, Karlson KH Jr. Medical resident driving simulator performance following a night on call. Behav Sleep Med 2006; 4: 112.
  • 28
    Lee HC, Lee AH, Cameron D. Validation of a driving simulator by measuring the visual attention skill of older adult drivers. Am J Occup Ther 2003; 57: 324328.
  • 29
    Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25(Suppl 1): 39.
  • 30
    Nyberg SL, Baskin-Bey ES, Mitchell MM, Bida JP, Schneider NK, Smith GE, et al. Early experience with HEADS: Hepatic encephalopathy assessment driving simulator. Advances in Transportation Studies 2006: 5362.
  • 31
    Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. HEPATOLOGY 2002; 35: 440446.
  • 32
    Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 1319.
  • 33
    Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280: 747749.
  • 34
    Hort J, Laczo J, Vyhnalek M, Bojar M, Bures J, Vlcek K. Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci U S A 2007; 104: 40424047.
  • 35
    Maguire EA, Burgess N, O'Keefe J. Human spatial navigation: cognitive maps, sexual dimorphism, and neural substrates. Curr Opin Neurobiol 1999; 9: 171177.
  • 36
    Zafiris O, Kircheis G, Rood HA, Boers F, Haussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 2004; 22: 541552.
  • 37
    McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. HEPATOLOGY 2005; 41: 801808.
  • 38
    Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231238.
  • 39
    McNaughton BL, Barnes CA, Gerrard JL, Gothard K, Jung MW, Knierim JJ, et al. Deciphering the hippocampal polyglot: the hippocampus as a path integration system. J Exp Biol 1996; 199: 173185.
  • 40
    Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. HEPATOLOGY 1997; 26: 14101414.
  • 41
    Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. HEPATOLOGY 2007; 45: 549559.